戻る Agenda
Session 10: European Regulatory Updates
Session Chair(s)
Sarah Vaughan
Head of Vigilance Operations
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
This session will provide updates from the UK’s Medicines & Healthcare products Regulatory Agency, the Danish Medicines Agency and the Netherlands Medicines Evaluation Board. The three speakers will share their current and upcoming work priorities and key challenges for the Regulatory Agencies in pharmacovigilance & risk management for 2021 and beyond.
Learning Objective : - Understand the current landscape for pharmacovigilance regulation in Europe.
- Describe the upcoming work priorities for MHRA, DKMA and MEB in their regulatory roles.
- Discuss the challenges and opportunities identified for future pharmacovigilance activities in Europe
Speaker(s)
Speaker
Sarah Vaughan
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Head of Vigilance Operations
Speaker
Anja Van Haren, MSC
Medicines Evaluation Board (MEB), Netherlands
Eudravigilance coordinator